Cognitive impairment in 873 patients with idiopathic Parkinson's disease
- 889 Downloads
Parkinson's disease (PD) is often accompanied by non-motor complications, such as dementia, depression, and psychotic symptoms, which worsen the prognosis and increase the personal and socioeconomic burden of disease. Prevalence estimates of these complications are quite variable and are lacking for the outpatient care sector.
As part of a larger, nationwide, cross-sectional epidemiological study in n = 315 neurological outpatient settings in Germany, this paper estimates the frequency of dementia and cognitive impairment in n = 873 outpatients meeting the UK Brain Bank criteria for idiopathic PD. Assessments were based on a clinical interview and neuropsychological assessments, including the Hoehn & Yahr rating and Unified Parkinson's Disease Rating Scale (UPDRS). Cognitive impairment was assessed by the Mini-Mental State Exam (MMSE), Clock Drawing Test (CDT) and the Parkinson Neuropsychometric Dementia Assessment (PANDA) and the clinician's diagnosis of dementia was based on the diagnostic criteria of DSMIV.
Using standardized cutoff scores, the prevalence of cognitive impairment in the study sample as measured by various methods was 17.5% by MMSE (≤ 24), 41.8% by CDT (≥ 3), 43.6% by PANDA (≤ 14), and 28.6% met the DSM-IV criteria for dementia. All estimates increased with age and PD severity. Gender was an inconsistent contributor while illness duration had no significant impact on cognition. Multiple regression analyses revealed PD severity to be the strongest predictor of dementia risk (OR = 4.3; 95% CI: 2.1–9.1), while neuropsychiatric syndromes had independent, although modest additional contributions (OR = 2.5, 95% CI: 1.6–3.8).
Estimates of cognitive impairment and dementia in PD patients are largely dependent on the diagnostic measure used. Using established clinical diagnostic standards for dementia the overall rate on routine outpatient neurological care is 28.6%, but using more sensitive neuropsychological measures, rates for cognitive impairment might be up to 2-fold higher. The MMSE revealed strikingly low sensitivity. Neuropsychiatric syndromes, in addition to PD severity and age, have an independent – although modest – additional contribution to patients' risk for cognitive impairment and dementia.
Key wordsParkinson's disease dementia cognitive impairment MMSE CDT PANDA
Unable to display preview. Download preview PDF.
- 3.Aarsland D, Larsen JP, Lim NG, Janvin C, Karlsen K, Tandberg E, Cummings J (1999) Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Ps 67:492–496Google Scholar
- 5.American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders – Text revision. American Psychiatric Association, Washington, DCGoogle Scholar
- 8.Efron B, Tibshirani R (1993) An introduction to the bootstrap. Chapman and Hall, LondonGoogle Scholar
- 10.Fahn S (1987) Unified Parkinson's Disease Rating Scale. In: Fahn S, Calne D (eds) Recent Developments in Parkinson's Disease. MacMillan Healthcare Information, Florham Park, NJ, pp 153–163Google Scholar
- 14.Hughes A, Daniel S, Kilford L, Lees A (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Ps 55:181–184Google Scholar
- 17.Kalbe E, Calabrese P, Kohn N, Hilker R, Riedel O, Wittchen HU, Dodel R, Otto J, Ebersbach G, Kessler J (2007) Screening for cognitive deficits in Parkinson's Disease with the Neuropsychometric Dementia Assessment (PANDA) instrument. Parkinsonism Relat D (in press)Google Scholar
- 25.National Institute of Mental Health (1976) CGI: Clinical Global Impressions. National Institute of Mental Health, Chevy Chase, MDGoogle Scholar
- 28.Riedel O, Dodel R, Spottke A, Deuschl G, Forstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Wittchen H-U (2006) Wie beurteilen Arzte die Haufigkeit demenzieller, depressiver und psychotischer Symptome bei Patienten mit der Parkinson- Krankheit? Eine Befragung von 500 Facharzten im ambulanten Versorgungssektor Deutschlands. Aktuel Neurol 33:374–380CrossRefGoogle Scholar